"Texas Digestive Disease Consultants is a professional association of exceptionally well trained gastroenterologists brought together as a single, organized entity in 1995. We provide the highest quality of care for patients with digestive problems in the states of Texas and Louisiana. Board certified gastroenterologists, together with the support of an excellent staff, provide the full spectrum of care for patients with concerns involving the esophagus, stomach, small bowel, colon, rectum, gallbladder, pancreas and liver. Inpatient and outpatient consultations, as well as a full range of endoscopic, diagnostic, and therapeutic procedures, are available by referral from the primary physician or can be self-directed."

During the past decade, GI Alliance conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "GI Alliance" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Janssen, LP" with 1 trials as a collaborator, "Mayo Clinic" with 1 trials as a collaborator and "University of Wisconsin, Madison" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "GI Alliance" are "Crohn's Disease" (1 trials) and "Inflammatory Bowel Diseases" (1 trials). Many other conditions were trialed in "GI Alliance" in a lesser frequency.

Most popular intervention types in "GI Alliance" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "COVID-19 Vaccine" (1 trials), "Etrasimod" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "GI Alliance" are 2 trials for "All" genders.

Currently, there are NaN active trials in "GI Alliance". 1 are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in GI Alliance, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in GI Alliance, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".